STAT· @statnews · X·· 2026-10-08AI 评分42
AI 导读
在杜氏肌营养不良症领域,一种有前景的疗法仅惠及少数幸运患者。一款强效新药的消息让家长们纷纷呼吁企业加快步伐。https://www.statnews.com/2026/10/07/muscular-dystrophy-exon-skipping-drugs-novartis-dyne/
正文
In Duchenne muscular dystrophy, a promising therapy is available to a fortunate few. Word of a potent new medicine has parents clamoring for companies to move faster. https://www.statnews.com/2026/10/07/muscular-dystrophy-exon-skipping-drugs-novartis-dyne/
来源:STAT · x.com